FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/095149 [Registered on: 19/09/2025] Trial Registered Prospectively
Last Modified On: 12/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To compare motor and sensory block characteristics in diabetic and non diabetic patients and comparing effect of two different spinal drugs in each group 
Scientific Title of Study   Evaluation of sensory and motor block characteristics of spinal anaesthesia in diabetic and non diabetic patients undergoing infra umbilical surgeries using 0.5 percent hyperbaric bupivacaine and 0.75 percent hyperbaric ropivacaine. A randomised controlled study 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Prachi Gupta  
Designation  Post Graduate Resident  
Affiliation  Maulana Azad medical College  
Address  Department of Anaesthesiology and intensive care Maulana Azad Medical College

Central
DELHI
110002
India 
Phone  9891449305  
Fax    
Email  prachigupta598@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Munisha Agarwal  
Designation  Director professor and Dean 
Affiliation  Maulana Azad medical College  
Address  Deans office Maulana Azad Medical College

Central
DELHI
110002
India 
Phone  9968604216  
Fax    
Email  munisha.agarwal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Prachi Gupta  
Designation  Post Graduate Resident  
Affiliation  Maulana Azad medical College  
Address  Department of Anaesthesiology and intensive care Maulana Azad Medical College

Central
DELHI
110002
India 
Phone  9891449305  
Fax    
Email  prachigupta598@gmail.com  
 
Source of Monetary or Material Support  
Maulana Azad Medical College and lok nayak hospital, 2 Bahadur Shah Zafar Marg, new delhi-110002, India 
 
Primary Sponsor  
Name  Maulana Azad Medical College  
Address  2, Bahadur Shah Zafar Marg, near Delhi Gate, Maulana Azad Medical College Campus, Balmiki Basti, New Delhi, Delhi, 110002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIl   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prachi Gupta  Maulana Azad Medical College and associated Lok Nayak Hospital   Ot block, Bahadur Shah Zafar Marg, near Delhi Gate, Maulana Azad Medical College Campus, Balmiki Basti, New Delhi, Delhi, 110002
Central
DELHI 
9891449305

prachigupta598@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
MAMC Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E119||Type 2 diabetes mellitus without complications, (2) ICD-10 Condition: K40-K46||Hernia, (3) ICD-10 Condition: M00-M99||Diseases of the musculoskeletal system and connective tissue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  spinal anaesthesia using hyperbaric bupivacaine  comparing motor and sensory block characteristics using hyperbaric bupivacaine in non diabetic and diabetic patients at every minute for first 10 min, then every 2 min for the next 10 min. No rise in sensory block for 2 consecutive readings will be taken as maximum sensory block level. Time to reach T10 dermatomal level and maximum sensory block level will be noted. Simultaneously, Motor block will be assessed at the same time points. Time to achieve onset of motor block (Modified Bromage score 1), maximum motor block achieved and time to reach maximum motor block will be noted. Thereafter, sensory and motor block will be assessed every 15 min for 2 segment sensory level regression and return to Modified Bromage score 1 respectivel 
Intervention  spinal anesthesia using hyperbaric ropivacaine  comparing motor and sensory block characteristics using hyperbaric ropivacaine in non diabetic and diabetic patients at every minute for first 10 min, then every 2 min for the next 10 min. No rise in sensory block for 2 consecutive readings will be taken as maximum sensory block level. Time to reach T10 dermatomal level and maximum sensory block level will be noted. Simultaneously, Motor block will be assessed at the same time points. Time to achieve onset of motor block (Modified Bromage score 1), maximum motor block achieved and time to reach maximum motor block will be noted. Thereafter, sensory and motor block will be assessed every 15 min for 2 segment sensory level regression and return to Modified Bromage score 1 respectively 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.height between 150-180cm
2.BMI between 19-30kg per meter square
3.ASA grade 1,2,3 
 
ExclusionCriteria 
Details  1.pregnancy
2.patients with known hypersensitivity to known drugs
3.patients with overt sensory sensory or motor deficit suggestive of diabetic neuropathy 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
mean time to 2 segment regression of sensory block level  every 15 minute after achieving maximum sensory block level 
 
Secondary Outcome  
Outcome  TimePoints 
mean time to achieve onset of sensory block (T10 dermatomal level)  every 1 minute for first 10 min , then every 2 minute for next 10 min 
maximum sensory block achieved   every 1 minute for first 10 min then every 2 min for next 10 min 
Mean time to achieve maximum sensory block level  Every 1 minute for first 10 minutes then every 2 min for the next 10 minutes  
Mean time to achieve onset of motor block ( modified bromage score 1)  Every 1 minute for first 10 minutes then every 2 min for the next 10 minutes  
Maximum motor block achieved   Every 1 minute for first 10 minutes then every 2 min for the next 10 minutes  
Mean time to achieve maximum motor block  Every 1 minute for first 10 minutes then every 2 min for the next 10 minutes  
Mean time to achieve regression of motor block ( from maximum block to modified bromage score 1)  Every 15 minute after achieving maximum block level 
 
Target Sample Size   Total Sample Size="56"
Sample Size from India="56" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This randomized controlled study aims to evaluate and compare the sensory and motor block characteristics of spinal anaesthesia in diabetic and non-diabetic patients undergoing infraumbilical surgeries using two local anaesthetics 0.5 percent hyperbaric bupivacaine and 0.75 percent hyperbaric ropivacaine. Diabetes mellitus is known to alter nerve conduction and sensitivity to local anaesthetics, potentially influencing block dynamics. The study will assess onset time, peak block level, and regression of both sensory and motor blocks, as well as the effect of CSF sugar and protein levels on these characteristics. A total of 56 patients will be randomized into four groups (diabetic/non-diabetic and bupivacaine/ropivacaine). The findings will help guide safer and more effective anaesthetic drug selection, particularly for diabetic patients, and support enhanced recovery practices in infra umbilical surgeries.

 
Close